IGFBP-6 and prognosis in patients with advanced nasopharyngeal carcinoma and nasopharyngeal carcinoma cells in the proliferation of the role CNE2.docVIP

  • 5
  • 0
  • 约2.11万字
  • 约 18页
  • 2017-05-03 发布于浙江
  • 举报

IGFBP-6 and prognosis in patients with advanced nasopharyngeal carcinoma and nasopharyngeal carcinoma cells in the proliferation of the role CNE2.doc

IGFBP-6 and prognosis in patients with advanced nasopharyngeal carcinoma and nasopharyngeal carcinoma cells in the proliferation of the role CNE2

 PAGE \* MERGEFORMAT 18 IGFBP-6 and prognosis in patients with advanced nasopharyngeal carcinoma and nasopharyngeal carcinoma cells in the proliferation of the role CNE2 Study: Raymond Mak, Chen Qiuyan LU Yi Zhang Jianguo Huang Ming-Qiang [Abstract] [Objective] To investigate insulin-like growth factor binding protein -6 (IGFBP-6) in nasopharyngeal carcinoma tissue pathology in patients with nasopharyngeal carcinoma and its clinical features and prognosis of nasopharyngeal carcinoma cell line effect. [Methods] Immunohistochemistry detected 76 cases of patients with advanced nasopharyngeal carcinoma pathological expression of IGFBP-6, and IGFBP-6 expression and the clinical characteristics and prognosis of NPC patients explore the relationship between; by MTS method Detection of IGFBP-6 CNE2 nasopharyngeal carcinoma cell line proliferation. [results] IGFBP-6 expression in NPC-negative group and positive group of patients with 5-year overall survival rates were 27% and 73% (survival analysis P = 0.007), 5-year local recurrence-free survival rates were 38% and 75% (P = 0.001), 5 years, distant metastasis-free survival rates were 53% and 89% (P = 0.002). Cox multivariate analysis The expression of IGFBP-6 showed 76 cases of nasopharyngeal carcinoma patients independent prognostic factors (P = 0.002), IGFBP-6 expression in patients with local recurrence and distant metastasis risk reduction. MTS results showed that IGFBP-6 can inhibit the nasopharyngeal carcinoma cell growth and proliferation of CNE2 (P lt;0.05), and this effect was dose dependent. [Conclusion] nasopharyngeal carcinoma is the expression of IGFBP-6 in patients with advanced nasopharyngeal carcinoma and locoregional recurrence Risk factors related to distant metastasis, the positive expression in patients with local recurrence and distant metastasis risk reduction. In vitro MTS proved CNE2 IGFBP-6 can inhibit proliferation. [Keywords:] nasopharyngeal carcinoma; IGFBP-6; prognosis; proliferati

文档评论(0)

1亿VIP精品文档

相关文档